|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, June 25, 2015 ) This report covers the present scenario and the growth prospects of the global colorectal cancer drugs market for the period 2015-2019. To calculate the market size, the report considers revenue generated from sales of various drugs used in the treatment of colorectal cancer.
Based on the type of molecule, the market is grouped into two categories:
Biologics
Small molecules
Based on the route of administration, the market is grouped into two categories:
Oral
Parenteral
This report covers the present scenario and the growth prospects of the global colorectal cancer drugs market for the period 2015-2019 in the following regions:
Americas: The principal countries focused upon in this region are the US, Canada, Mexico, and Brazil
EMEA: The principal countries focused upon in this region are the UK, Germany, Italy, France, Spain, Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and UAE. Germany, Italy, and the UK are the leading European countries in terms of elderly population
APAC: The principal countries focused upon in this region are Japan, China, Australia, Singapore, South Korea, and India.
The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors as well as the competitive performances of their product portfolios in the market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market.
The report, Global Colorectal Cancer Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the global colorectal cancer drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Colorectal cancer refers to malignancies that originate in the rectum or the colon. It is also known as bowel cancer. Formation of adenocarcinomas is the most common feature of colorectal cancer. The cancer starts as a polyp in the inner wall of the colon or rectum. These polyps can be benign or malignant. Colorectal cancer is the third most common cancer in the US. Some of the risk factors that can cause colorectal cancer are lifestyle changes, old age, genetic disorders, family history, and inflammatory bowel disease. Some of the symptoms of colorectal cancer are blood in stool, decrease in appetite, constipation, weight loss, nausea, bloating, and pelvic pain. Colorectal cancer can be classified into four broad stages. Colorectal cancer can be treated using surgical, chemotherapeutic, biologic, and radiation therapies.
The analysts forecast the global colorectal cancer drugs market to grow at a CAGR of 3.62% over the period 2014-2019.
Purchase a Report Copy at http://www.rnrmarketresearch.com/contacts/purchase?rname=393302 .
Key Regions
Americas
APAC
EMEA
Key Vendors
Amgen
Bayer
Bristol-Myers Squibb
F. Hoffmann-La Roche
Merck Serono
Other Prominent Vendors
Accord Healthcare
Advenchen Laboratories
Aeterna Zentaris
AstraZeneca
Bavarian Nordic
Biothera
Boehringer Ingelheim
Daiichi Sankyo
Debiopharm
Eisai
Eli Lilly
Immodulon Therapeutics
Mologen
Mylan
Nektar Therapeutics
Oncothyreon
Otsuka Pharmaceutical
Precision Biologics
Sun Pharmaceutical
Symphogen
Taiho
Takeda
Teva
ThromboGenics
Xbiotech
Yakult Honsha
Inquire before Buying at http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=393302 .
Market Driver
Increase in population of patients
Market Challenge
Loss of patent exclusivity
Market Trend
Dominance of biologics
Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be
What are the key market trends
What is driving this market
What are the challenges to market growth
Who are the key vendors in this market space
What are the market opportunities and threats faced by the key vendors
What are the strengths and weaknesses of the key vendors
Inquire for Discount at http://www.rnrmarketresearch.com/contacts/discount?rname=393302 .
About Us:
RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
RnR Market Research
Ritesh Tiwari
1 888 391 5441
sales@rnrmarketresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
